VinayendraKumarJainMD

Internal Medicine • Brooklyn, NY

Assistant Professor, Psychiatry, SUNY-Downstate College of Medicine

Join to view full profile

Are you Dr. Jain?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 15 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
600 Albany Ave
Brooklyn, NY 11203
Phone+1 718-245-2629
Is this information wrong?

Summary

Dr. Vinayendra Jain, MD is an internist in Brooklyn, New York. He is currently licensed to practice medicine in New York. He is an Assistant Professor at SUNY-Downstate College of Medicine.

Education & Training

New York Medical College (Brooklyn-Queens)Residency, Internal Medicine, 1974 - 1976
Gandhi Medical CollegeClass of 1969

Certifications & Licensure

NY State Medical License Active through 2014

Publications & Presentations

PubMed

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.
Keating, M. J., Flinn, I., Jain, V., Binet, J. L., Hillmen, P., Byrd, J., Albitar, M., Brettman, L., Santabarbara, P., Wacker, B., Rai, K. R.> ;Blood. 2002 May 15
Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-cell lymphoma, progressive after rituximab.
Horning, S. J., Younes, A., Jain, V., Kroll, S., Lucas, J., Podoloff, D., Goris, M.> ;J Clin Oncol. 2005 Feb 1
Evaluation of thymic output by measurement of T-cell-receptor gene rearrangement excisional circles (TREC) in patients who have received fludarabine.
Aquino, V. M., Douek, D. C., Berryman, B., Johnson, M., Jain, V. K., Collins, R. H.> ;Leuk Lymphoma. 2003 Feb
Highlights from: 27th congress of the European Society for Medical Oncology. Nice, France. October 18-22, 2002.
Maung, K., Lee, D., DeGrendele, H. C., Schilsky, R., Chu, E., Jain, V. K., Copur, S.> ;Clin Colorectal Cancer. 2002 Nov
Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma.
Wilder, D. D., Ogden, J. L., Jain, V. K.> ;Clin Lymphoma. 2002 Mar
The Role of Plerixafor (AMD3100) in Mobilizing Hematopoietic Progenitor Cells in Patients with Hematologic Malignancies.
Reddy, G. K., Crawford, J., Jain, V. K.> ;Support Cancer Ther. 2006 Jan 1
Denosumab (AMG 162), a Fully Human Monoclonal Antibody Against RANK Ligand Activity.
Reddy, G. K., Nadler, E., Jain, V. K.> ;Support Cancer Ther. 2005 Oct 1
Therapeutic use of the cannabinoid receptor antagonist rimonabant in weight loss and smoking cessation.
Tyagi, P., Jain, V. K., Nadler, E.> ;Support Cancer Ther. 2005 Oct 1
Highlights from: The 9th International Congress on Hematologic Malignancies, Whistler, BC, Canada.
Redd, G. K., Tyagi, P., Nadler, E., Jain, V. K.> ;Support Cancer Ther. 2005 Oct 1
Palifermin is efficacious in reducing oral mucositis induced by intensive cancer therapy.
Reddy, G. K., Jain, V. K.> ;Support Cancer Ther. 2005 Jan 1
Highlights from: The 46th Annual Meeting of the American Society of Hematology; San Diego, CA.
Reddy, G. K., Jain, V. K., Crawford, J.> ;Support Cancer Ther. 2005 Jan 1
Rasburicase for prevention of hyperuricemia and tumor lysis syndrome.
Reddy, K., Goldman, S., Jain, V. K.> ;Support Cancer Ther. 2004 Jan 1
New strategies for the treatment of chemotherapy-induced diarrhea.
Maung, K., Copur, M. S., Jain, V. K.> ;Support Cancer Ther. 2004 Jan 1
Role of psychostimulants in the management of cancer-related fatigue in patients with advanced cancer.
Reddy, K., Jain, V. K., Nadler, E.> ;Support Cancer Ther. 2005 Jul 1
Deferasirox (ICL670; Exjade(R)), a Novel Orally Available Iron Chelator for Correction of Transfusion-Associated Iron Overload.
Tyagi, P., Jain, V. K., Crawford, J.> ;Support Cancer Ther. 2005 Jul 1
Highlights from: The 41st Annual Meeting of the American Society of Clinical Oncology; Orlando, FL.
Reddy, G. K., Jain, V. K., Nadler, E., Crawford, J.> ;Support Cancer Ther. 2005 Jul 1
Novel thrombopoetin mimetic agents with potential to ameliorate chemotherapy-induced thrombocytopenia.
Tyagi, P., Crawford, J., Jain, V. K.> ;Support Cancer Ther. 2005 Apr 1
Incidence of thromboembolism and role of low molecular weight heparin in prolonging survival in patients with advanced malignancies.
Reddy, G. K., Jain, V. K., Deitcher, S.> ;Support Cancer Ther. 2004 Oct 1
Prevention and management of osteonecrosis of the jaw associated with bisphosphonate therapy.
Price, N., Lipton, A., Jain, V. K., Ruggiero, S.> ;Support Cancer Ther. 2004 Oct 1
Kyphoplasty in the management of cancer-associated vertebral compression fractures.
Reddy, G. K., Jain, V. K.> ;Support Cancer Ther. 2004 Oct 1
Current strategies to minimize treatment-associated hot flashes in patients with breast cancer.
Reddy, G. K., Jain, V. K., Loprinzi, C.> ;Support Cancer Ther. 2004 Jul 1
Prophylactic pegfilgrastim significantly reduces febrile neutropenia during moderately myelosuppressive chemotherapy.
Price, N., Jain, V. K., Lyman, G. H.> ;Support Cancer Ther. 2004 Jul 1
Highlights from: The 40th Annual Meeting of the American Society of Clinical Oncology; New Orleans, LA.
Price, N., Reddy, G. K., Jain, V. K., Navari, R.> ;Support Cancer Ther. 2004 Jul 1
Impact of correction of anemia on clinical outcome in patients with cancer: recent data from head and neck and breast cancer trials.
Gibson, A. D., Crawford, J., Jain, V. K.> ;Support Cancer Ther. 2004 Apr 1
Control of chemotherapy-induced emesis with 5-hydroxytryptamine-3 antagonists.
Price, N., Jain, V. K.> ;Support Cancer Ther. 2004 Apr 1
Join now to see all